Intralesional cidofovir as neoadjuvant therapy in a squamous cell carcinoma of the nail bed

Dermatol Ther. 2021 Jan;34(1):e14681. doi: 10.1111/dth.14681. Epub 2020 Dec 23.

Authors

Ana Pulido-Pérez¹, Verónica Parra-Blanco², Marta Bergón-Sendín¹, Fernando Carretero-López³, Lula Mª Nieto-Benito¹, Ángel Rosell-Díaz¹, Rosa Romero-Jiménez⁴, Ricardo Suárez-Fernández¹

Affiliations

¹ Department of Dermatology, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
² Department of Pathology, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
³ Department of Radiology, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
⁴ Department of Pharmacy, Hospital General Universitario Gregorio Marañón, Madrid, Spain.

PMID: 33320973
DOI: 10.1111/dth.14681

No abstract available

Publication types

Letter

MeSH terms

Antiviral Agents / therapeutic use
Carcinoma, Squamous Cell* / drug therapy
Cidofovir
Cytosine
Humans
Injections, Intralesional
Nail Diseases* / drug therapy
Neoadjuvant Therapy

Substances

Antiviral Agents
Cytosine
Cidofovir